Last week, a California jury ruled in favor of Johnson & Johnson in a Stevens Johnson Syndrome lawsuit which alleged that the ibuprofen in Children's Motrin caused an 11-year-old girl to develop a severe skin reaction, which blinded her. >>INFORMATION: Stevens Johnson Syndrome (SJS) Lawsuits (more…) Read More
Following several years of concern about the increased risk of tendon ruptures associated with Levaquin, the FDA announced last week that a black box warning would be added to the antibiotic and other fluoroquinolone antimicrobial drugs, such as Cipro and Floxin. Users will also now receive… Read More
On Tuesday, the FDA announced that they are requiring the makers of fluoroquinolone antibiotics, such as Cipro and Levaquin, to add a black box warning about an increased risk of tendinitis and tendon ruptures. They are also requiring that patients receive a Medication Guide highlighting the… Read More
The antibiotics Cipro and Levaquin have been associated with an increased risk of tendon ruptures, particularly involving the Achilles tendon. Despite a disturbing number of reports of problems, the manufacturers have failed to adequately warn about the risk of tendon damage and many users have not… Read More
Popular antibiotics known as fluoroquinolones, which include Cipro and Levaquin, have been associated with a potential increased risk of ruptured tendons. Although this risk has been known for some time, manufacturers of these antibiotics provide inadequate warnings to doctors and consumers. As a result, users continue… Read More
The consumer protection group Public Citizen has filed a federal lawsuit against the FDA regarding tendon problems associated with fluoroquinolone antibiotics. They are asking the court to require the federal drug regulators to act on a petition filed 16 months ago requesting that new warnings be… Read More
The FDA issued an early communication yesterday regarding a possible increased risk of death associated with Maxipime, an antibiotic injection used for pneumonia and other serious infections. The federal drug regulators are reviewing safety data and have requested additional information from the manufacturer to complete a… Read More
The FDA reported today that a new warning will be added to Rocephin for Injection, an antibiotic manufactured by Roche Holding AG. When combined with calcium or calcium-containing products, the antibiotic could cause a fatal reaction in the lungs and kidneys of newborn babies, especially those… Read More
According to an FDA advisory committee, the dangers of Ketek liver damage outweigh the potential benefits of the antibiotic when used to treat certain conditions. The committee has recommended that the manufacturer no longer be permitted to market the antibiotic for treatment of sinusitis or bronchitis,… Read More
An FDA staff drug reviewer has openly criticized the continued use of the antibiotic Ketek in a letter to the New England Journal of Medicine published on November 23, 2006. Ketek side effects have included liver failure and death which the manufacturer did not adequately warn… Read More
